Carna Biosciences, Inc. (TYO:4572)
Japan · Delayed Price · Currency is JPY 300.00
-6.00 (-1.96%)
Aug 1, 2025, 3:30 PM JST
Revance Therapeutics Market Cap
Carna Biosciences has a market cap or net worth of 5.97 billion as of August 1, 2025. Its market cap has decreased by -11.85% in one year.
Market Cap
5.97B
Enterprise Value
4.46B
Revenue
598.71M
Ranking
n/a
PE Ratio
n/a
Stock Price
$300.00
Market Cap Chart
Since March 25, 2008, Carna Biosciences's market cap has increased from 4.63B to 5.97B, an increase of 28.95%. That is a compound annual growth rate of 1.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 5.97B | 4.14% |
| Dec 30, 2024 | 5.73B | -35.99% |
| Dec 29, 2023 | 8.95B | 21.11% |
| Dec 30, 2022 | 7.39B | -49.61% |
| Dec 30, 2021 | 14.67B | -2.43% |
| Dec 30, 2020 | 15.03B | -38.91% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Chugai Pharmaceutical | 12.19T |
| Daiichi Sankyo Company | 6,804.03B |
| Takeda Pharmaceutical Company | 6,709.66B |
| HOYA Corporation | 6,488.42B |
| Otsuka Holdings | 3,820.98B |
| Terumo | 3,754.49B |
| Astellas Pharma | 2,663.98B |
| Shionogi & | 2,151.21B |